All of these results suggested that wogonoside might inhibit the proliferation of human colon cancer cells in the conditioned media from LPS-activated THP-1 cells via suppressing NF-κB activation through PI3K/Akt pathway. Here, NFKB1 is linked to colonic neoplasm.